The Trump administration is set to unveil a plan to remove petroleum-based synthetic dyes from the country’s food supply, ...

Some states have already moved to restrict some synthetic dyes and the FDA banned Red 3 from the nation’s food supply.

The delay dovetails with moves by Republican lawmakers in at least 7 states to ban or limit mRNA vaccines. HealthDay News — The US Food and Drug Administration (FDA) has delayed the full ...

Cabozantinib significantly improved outcomes in this patient population and this FDA approval provides new hope.” Approval of cabozantinib was granted to Exelixis.

FRIDAY, April 4, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has delayed the full approval of Novavax’s COVID-19 vaccine. The decision had been expected by April 1 ...

Most survey respondents were unaware of US Food and Drug Administration (FDA)-approved treatments for hidradenitis suppurativa (HS), and only 18% were satisfied with their current management.

The U.S. Food and Drug Administration (FDA) has approved Qfitlia, a groundbreaking hemophilia treatment by French pharmaceutical giant Sanofi (NASDAQ: SNY).Designed for patients aged 12 and older ...

Qfitlia Becomes the Sixth Alnylam-Discovered RNAi Therapeutic Approved by U.S. FDA and First and Only to Treat Hemophilia A or B With or Without Inhibitors – Alnylam Pharmaceuticals, Inc ...

Based on these data, the U.S. Food and Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) seeking approval of subcutaneous pembrolizumab across all previously ...

The Montreal biopharmaceutical company, which was seeking FDA approval of etripamil for the conversion of acute episodes of paroxysmal supraventricular tachycardia, or PSVT, to sinus rhythm in ...

A settlement between Amgen and Fresenius Kabi will permit the biosimilar to launch in mid-2025 in the U.S. Perspective from Ruban Dhaliwal, MD, MPH The FDA has approved two new denosumab ...